Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae
about
Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010.E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.Determination of trimethoprim-sulfamethoxazole resistance in Streptococcus pneumoniae by using the E test with Mueller-Hinton agar supplemented with sheep or horse blood may be unreliable. The Pneumococcal Study Group.Evaluation of the PASCO strep plus broth microdilution antimicrobial susceptibility panels for testing Streptococcus pneumoniae and other Streptococcal species.Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeastsDetermination of penicillin MICs for Streptococcus pneumoniae by using a two- or three-disk diffusion procedure.Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniaeReliability of pasco MIC system for use in detection of resistant Streptococcus pneumoniae.Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniaeHigh prevalence of penicillin-nonsusceptible Streptococcus pneumoniae at a community hospital in Oklahoma.Comparison of BD phoenix to vitek 2, microscan MICroSTREP, and Etest for antimicrobial susceptibility testing of Streptococcus pneumoniae.Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilutionEvaluation of CLSI agar dilution method and Trek Sensititre broth microdilution panel for determining antimicrobial susceptibility of Streptococcus pneumoniae.
P2860
Q33798133-1F3949A6-8318-4963-8A14-14C445E12136Q33957980-09C66310-1E1B-4C26-9C72-10D8CB9AFC44Q33958232-698B837B-E5C6-47AB-8EF7-E1214F45129DQ33966759-D533E61B-2253-4E8C-8EE1-B8CC5835F398Q33967445-6B29FA92-7C43-441B-9EA9-13F765DCBA22Q34073085-A1D4CEEF-E273-47BA-8110-A60614DB51B2Q34469936-4208098F-958B-4D0A-89F7-FD04AD17DBB0Q36527617-C165252A-5C0B-4913-9564-4621F2E2C039Q36540874-C51ED2C9-CB2C-4B98-BDD6-AB8792B775D5Q37093936-BCEA1C94-AA63-4837-99B2-C5439849EA82Q37410460-65FFD6BB-2155-4C08-8C81-C2C327DE99F6Q42432319-4C1E8D1F-7A17-4B48-B362-D87C6AC9A1EEQ42625640-F73E7770-6C27-491D-86EA-E5AE974A3291
P2860
Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Evaluation of commercial metho ...... ty of Streptococcus pneumoniae
@ast
Evaluation of commercial metho ...... ty of Streptococcus pneumoniae
@en
type
label
Evaluation of commercial metho ...... ty of Streptococcus pneumoniae
@ast
Evaluation of commercial metho ...... ty of Streptococcus pneumoniae
@en
prefLabel
Evaluation of commercial metho ...... ty of Streptococcus pneumoniae
@ast
Evaluation of commercial metho ...... ty of Streptococcus pneumoniae
@en
P2093
P2860
P1476
Evaluation of commercial metho ...... ty of Streptococcus pneumoniae
@en
P2093
P2860
P407
P577
1996-01-01T00:00:00Z